Skip to search formSkip to main contentSkip to account menu

NPC 12626

Known as: Cyclohexanepropanoic acid, alpha-amino-2-(2-phosphonoethyl)-, NPC-12626 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Amino AcidsExcitatory Amino Acid Antagonists

Narrower (2)

GPI 3000NPC 17742

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Competitive NMDA receptor antagonists differentially affect dopamine cell firing pattern
Alterations in the firing pattern of mesencephalic dopamine (DA) neurons appear to constitute a physiological mechanism through… 
1997
1997
( S )-( 2 )-HA-966 , a g-Hydroxybutyrate-Like Agent , Prevents Enhanced Mesocorticolimbic Dopamine Metabolism and Behavioral Correlates of Restraint Stress , Conditioned Fear and Cocaine…
This report investigates the effect of the negative enantiomer of 1-hydroxy-3-aminopyrrolidone-2 (HA-966) on behavioral and… 
1993
1993
Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist.
A drug discrimination based upon the competitive N-methyl-D-aspartate (NMDA) antagonist 2-amino-4,5-(1,2-cyclohexyl)-7… 
1993
1993
Effects of ethanol and NMDA antagonists on operant behavior in ethanol withdrawal seizure‐prone and -resistant mice
The acute effects of ethanol (EtOH) on fixed-ratio performance were studied in separate lines of mice selectively bred for… 
1992
1992
Antipunishment effects of acute and repeated administration of phencyclidine and NPC 12626 in rats.
1990
1990
Evidence for direct interactions between the NMDA and glycine recognition sites in brain.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)